Team:UTP-Panama/ Team's Perspective
From 2011.igem.org
(→METHODOLOGY) |
(→I.BACKGROUND) |
||
Line 23: | Line 23: | ||
b). Citando a Paul Ravinov, from Ravinov lab:<br> | b). Citando a Paul Ravinov, from Ravinov lab:<br> | ||
''We see developments in synthetic biology as an opportunity to invent new forms of collaborative practice. Standard approaches have sought to anticipate how new scientific developments will impact “society,” positioning themselves external to, and “downstream” of, the scientific work per se. This positioning, for example, was mandated by the Human Genome Initiative and the so-called ELSI project (ethical, legal, and social implications). By contrast, we are committed to an approach that fosters a co-production among disciplines and perspectives from the outset. The value of collaboration is that its goal is to build a synergistic and recursive structure within which significant challenges, problems, and achievements are more likely to be clearly formulated and successfully evaluated. Synthetic biology already represents a highly innovative assemblage of multiple scientific sub-disciplines, diverse forms of funding, complex institutional collaborations, serious forward-looking reflection, intensive work with governmental and non-governmental agencies, focused legal innovation, imaginative use of media, and the like. We begin with the assumption that from the outset, Thrust IV (SynBERC Thrust 4) must be an integral, if distinctive, part of this overall effort. It is a principle goal of Thrust IV to invent and sustain this form of collaboration''[2]'<br> | ''We see developments in synthetic biology as an opportunity to invent new forms of collaborative practice. Standard approaches have sought to anticipate how new scientific developments will impact “society,” positioning themselves external to, and “downstream” of, the scientific work per se. This positioning, for example, was mandated by the Human Genome Initiative and the so-called ELSI project (ethical, legal, and social implications). By contrast, we are committed to an approach that fosters a co-production among disciplines and perspectives from the outset. The value of collaboration is that its goal is to build a synergistic and recursive structure within which significant challenges, problems, and achievements are more likely to be clearly formulated and successfully evaluated. Synthetic biology already represents a highly innovative assemblage of multiple scientific sub-disciplines, diverse forms of funding, complex institutional collaborations, serious forward-looking reflection, intensive work with governmental and non-governmental agencies, focused legal innovation, imaginative use of media, and the like. We begin with the assumption that from the outset, Thrust IV (SynBERC Thrust 4) must be an integral, if distinctive, part of this overall effort. It is a principle goal of Thrust IV to invent and sustain this form of collaboration''[2]'<br> | ||
+ | |||
'''METHODOLOGY''' | '''METHODOLOGY''' |
Revision as of 03:38, 27 October 2011
Home |
Human Practices Home | Human Practices in Science | Outreach | SB UTP 1.0 | SB UTP PROJECT 1.0 |
I.BACKGROUNDPreguntarnos y reflexionar sobre que es el "Human Practices" y porque esta incluido en el iGEM competition, ya que muchos estudiantes sino le dicen que existe este reconocimiento y categoría, no lo ven obvio, o posiblemente no lo incluirían en sus proyectos de iGEM. Por ejemplo muchos equipos lo hacen como un requisito del concurso o como únicamente alguna actividad de outreach, sin dedicarse a profundizar en loque pudiera ser el "Human Practice". En nuestra búsqueda por hacer un human Practice Project, nos hemos encontrado con la reflexión sobre, ¿Qué es Human Practices? y ¿Por qué hay que hacerla?, y nos encontramos con algunas definiciones y modelos desarrollados y planeados por SynBerc[1] y por el Dr Paul Ravinov [2], los cuales nos plantean un "Human Practices" más amplio y profundo que un Outreach.
We decite to ask to our team members: II. TEAM'S ANSWERSDukakis: "Genetic manipulation has always been a controversial issue, an example is the clonation of the first mammal, Dolly the sheep, which further exacerbated the controversies. Years earlier, was the genetic manipulation of foods to make them resistant to pests and get better features, which began the debate on the necessity and the consequences of this practice. Recently there has appeared a new discipline, Synthetic Biology, and taking into account this background it is important in order to avoid prejudice and misconceptions,deeply assess the impact and implications of this discipline. Moreover, creating awareness in society about the benefits, risks, utilization and impact of Synbio for society in general as well as for science and technology. So I think it has been necessary to include within iGEM "Human Practices" to address the above."
Therefore it is strongly justified to implementing Human Practices because otherwise the applications that are planned to be develop will lack of purpose if they are not intended to improve the human life, animal and our planet. Awareness and a clear assimilation of the concepts of synthetic biology is the primary objective of Human Practices aspects in all iGEM competition projects."
The most common example is the production of food: making plants resistant to pests, more profitable or more nutritious. In the medicine is also used to produce new drugs and therapies that help to save lives. At the same time human practice also motivate researchers to develop useful projects for humanity. Who does not want to go down in history as the one who changed all the mankind for the good?"
- To achieve that orientation we need to know what we do.
III. CONCLUSIONReferences[1] Human Practices, Synthetic Biology Research Engineering Center. http://calfuel.org/humanpractices.html [2] FUNDAMENTAL HUMAN PRACTICES, Ravinov Lab. Openwetware. http://openwetware.org/wiki/Rabinow_lab |